Revigro Pharmaceutical Private Limited
About Revigro Pharmaceutical Private Limited
Data last updated:
Revigro Pharmaceutical Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24111MH2018PTC312958. Its GSTIN is 27AAJCR0959D1ZA (Maharashtra).
The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anil Kedarnath Yadav and Gyan Anil Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 159 B Wing Orchard Road Mall Goregaon East Royal Palms Survey No. 169 Aarey, Mumbai, Maharashtra, India – 400065.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.77 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹17,771 (net margin 0.9%) and EBITDA of ₹24,021 (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 67% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address159 B Wing Orchard Road Mall Goregaon East Royal Palms Survey No. 169 Aarey, Mumbai, Maharashtra, India – 400065
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Revigro Pharmaceutical Private Limited
The main business activity of Revigro Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Revigro Pharmaceutical Private Limited FY 2025 filings available
Revigro Pharmaceutical Private Limited reported revenue of ₹19.77 Lakh (up 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Revigro Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 67% over five years, including 1% growth in the latest year. EBITDA fell 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Revigro Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹24,021 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹17,771 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Revigro Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Revigro Pharmaceutical are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Revigro Pharmaceutical Private Limited
Revigro Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kedarnath Yadav | Director | 21 Aug 2018 | 8 Years 1 Months | Current |
| Gyan Anil Yadav | Director | 02 Feb 2024 | 2 Years 8 Months | Current |
Peer Comparison of Revigro Pharmaceutical Private Limited
Revigro Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Retail trade, except of motor vehicles and motorcycles). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Soumita Overseas Private Limited | ₹19.83 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | South Dinajpur, West Bengal, India |
| Bitbase Technologies Private Limited | ₹19.8 Lakh (FY 2025) | •••• | •••• | •••• | Kollam, Kerala, India | |
| Manam Lifestyle Private Limited | ₹19.79 Lakh (FY 2024) | •••• | •••• | 2389.0% | •••• | Mumbai, Maharashtra, India |
| Shree Aadishakti Logistics & Consultancy Private Limited | ₹19.79 Lakh (FY 2024) | •••• | •••• | •••• | Ulwe, Maharashtra, India | |
| October Store Private Limited | ₹19.78 Lakh (FY 2024) | •••• | •••• | •••• | Jammu, Jammu and Kashmir, India | |
| Revigro Pharmaceutical Private Limited this company | ₹19.77 Lakh (FY 2024) | •••• | •••• | 1.0% | •••• | Mumbai, Maharashtra, India |
| Oxyical (OPC) Private Limited | ₹19.77 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | Noida, Uttar Pradesh, India |
| Aura Holdiings Private Limited | ₹19.73 Lakh (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Ankit Securities and Finance Company Private Limited | ₹19.71 Lakh (FY 2025) | •••• | •••• | -44.0% | •••• | Mumbai, Maharashtra, India |
| Venturiq Energy Private Limited | ₹19.7 Lakh (FY 2025) | •••• | •••• | 3.0% | •••• | Kolhapur, Maharashtra, India |
| Dhruvi O Private Limited | ₹19.7 Lakh (FY 2025) | •••• | •••• | 2503.0% | •••• | Panchkula, Haryana, India |
Peers are the five companies nearest above and the five nearest below Revigro Pharmaceutical by revenue in the same principal business activity (Retail trade, except of motor vehicles and motorcycles), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Revigro Pharmaceutical Private Limited
Revigro Pharmaceutical Private Limited is audited by K M A & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K M A & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Revigro Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Revigro Pharmaceutical Private Limited
Revigro Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Revigro Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Revigro Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Revigro Pharmaceutical Private Limited
Revigro Pharmaceutical Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Gyan Anil Yadav ceased to be Additional Director on 29 Sep 2024.
Credit Ratings, Litigation & Regulatory Alerts for Revigro Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Revigro Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Revigro Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Revigro Pharmaceutical Private Limited
Revigro Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCR0959D1ZA | Maharashtra | Active | 11 Oct 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Revigro Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Revigro Pharmaceutical Private Limited
Revigro Pharmaceutical is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 August 2018 (8+ years old) and is registered under CIN U24111MH2018PTC312958.
Revigro Pharmaceutical reported revenue of ₹19.77 Lakh for FY 2024 (up 1% YoY).
Revigro Pharmaceutical has 2 current directors:
- Anil Kedarnath Yadav - Director
- Gyan Anil Yadav - Director
Revigro Pharmaceutical reported a net profit of ₹17,771 (net margin 0.9%) and EBITDA of ₹24,021 (EBITDA margin 1.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Revigro Pharmaceutical is 8% over three years and 67% over five years. In the latest year (FY 2024) revenue rose 1%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Revigro Pharmaceutical is 27AAJCR0959D1ZA, registered in Maharashtra.
The CIN (Corporate Identification Number) of Revigro Pharmaceutical is U24111MH2018PTC312958. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Revigro Pharmaceutical was incorporated on 21 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Revigro Pharmaceutical by revenue are Soumita Overseas Private Limited, Bitbase Technologies Private Limited, Manam Lifestyle Private Limited, Shree Aadishakti Logistics & Consultancy Private Limited, October Store Private Limited and 5 more, all in the same principal business activity (Retail trade, except of motor vehicles and motorcycles).
Gyan Anil Yadav ceased to be Additional Director on 29 Sep 2024. Anil Yadav ceased to be Director on 20 Feb 2024. Gyan Anil Yadav was appointed as Director on 02 Feb 2024. Revigro Pharmaceutical has 4 board changes on record in total.
The registered office of Revigro Pharmaceutical is at 159 B Wing Orchard Road Mall Goregaon East Royal Palms Survey No. 169 Aarey, Mumbai, Maharashtra, India – 400065.